Arecor Therapeutics plc

📍 Cambridge, United Kingdom🗓 Founded 2007👥 41 employees💰 Last funded Aug 2022
Biotechnology Research🌐 arecor.com
Website LinkedIn
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary formulation technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver enhanced formulations of their therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio.
4
Total investors
0
Early stage
1
Mid stage
0
Late stage
2007
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
4
Investor activity2011–2022 · investors recorded per year
20111201812021120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Arecor Therapeutics plc?
Arecor Therapeutics plc has 4 investors on record on gritt.io, 1 mid-stage.
When did Arecor Therapeutics plc last raise funding?
The most recent investment in Arecor Therapeutics plc recorded on gritt.io was in August 2022.
When was Arecor Therapeutics plc founded?
Arecor Therapeutics plc was founded in 2007.
What industry is Arecor Therapeutics plc in?
Arecor Therapeutics plc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Arecor Therapeutics plc based?
Arecor Therapeutics plc is headquartered in Cambridge, United Kingdom.